1152 related articles for article (PubMed ID: 32075939)
41. Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques.
Yang X; Wang X; Song Y; Zhou P; Li D; Zhang C; Jin X; Huang Z; Zhou D
Emerg Microbes Infect; 2019; 8(1):1086-1097. PubMed ID: 31339465
[TBL] [Abstract][Full Text] [Related]
42. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
43. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
44. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
[TBL] [Abstract][Full Text] [Related]
46. A Novel Bacterium-Like Particle-Based Vaccine Displaying the SUDV Glycoprotein Induces Potent Humoral and Cellular Immune Responses in Mice.
Xu S; Jiao C; Jin H; Li W; Li E; Cao Z; Shi Z; Yan F; Zhang S; He H; Chi H; Feng N; Zhao Y; Gao Y; Yang S; Wang J; Wang H; Xia X
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835785
[TBL] [Abstract][Full Text] [Related]
47. Enhanced
Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
[TBL] [Abstract][Full Text] [Related]
48. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
[TBL] [Abstract][Full Text] [Related]
49. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
Mire CE; Geisbert JB; Marzi A; Agans KN; Feldmann H; Geisbert TW
PLoS Negl Trop Dis; 2013; 7(12):e2600. PubMed ID: 24367715
[TBL] [Abstract][Full Text] [Related]
50. An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
Wu S; Kroeker A; Wong G; He S; Hou L; Audet J; Wei H; Zhang Z; Fernando L; Soule G; Tran K; Bi S; Zhu T; Yu X; Chen W; Qiu X
J Infect Dis; 2016 Oct; 214(suppl 3):S326-S332. PubMed ID: 27493239
[TBL] [Abstract][Full Text] [Related]
51. Chimpanzee Adenovirus Vector Ebola Vaccine.
Ledgerwood JE; DeZure AD; Stanley DA; Coates EE; Novik L; Enama ME; Berkowitz NM; Hu Z; Joshi G; Ploquin A; Sitar S; Gordon IJ; Plummer SA; Holman LA; Hendel CS; Yamshchikov G; Roman F; Nicosia A; Colloca S; Cortese R; Bailer RT; Schwartz RM; Roederer M; Mascola JR; Koup RA; Sullivan NJ; Graham BS;
N Engl J Med; 2017 Mar; 376(10):928-938. PubMed ID: 25426834
[TBL] [Abstract][Full Text] [Related]
52. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.
Ledgerwood JE; Costner P; Desai N; Holman L; Enama ME; Yamshchikov G; Mulangu S; Hu Z; Andrews CA; Sheets RA; Koup RA; Roederer M; Bailer R; Mascola JR; Pau MG; Sullivan NJ; Goudsmit J; Nabel GJ; Graham BS;
Vaccine; 2010 Dec; 29(2):304-13. PubMed ID: 21034824
[TBL] [Abstract][Full Text] [Related]
53. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.
Pratt WD; Wang D; Nichols DK; Luo M; Woraratanadharm J; Dye JM; Holman DH; Dong JY
Clin Vaccine Immunol; 2010 Apr; 17(4):572-81. PubMed ID: 20181765
[TBL] [Abstract][Full Text] [Related]
54. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
55. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.
Martinez O; Tantral L; Mulherkar N; Chandran K; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S825-32. PubMed ID: 21987758
[TBL] [Abstract][Full Text] [Related]
56. Designing Efficacious Vesicular Stomatitis Virus-Vectored Vaccines Against Ebola Virus.
Wong G; Qiu X
Methods Mol Biol; 2016; 1403():245-57. PubMed ID: 27076134
[TBL] [Abstract][Full Text] [Related]
57. Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice.
Lehrer AT; Wong TS; Lieberman MM; Humphreys T; Clements DE; Bakken RR; Hart MK; Pratt WD; Dye JM
Vaccine; 2018 May; 36(22):3090-3100. PubMed ID: 28216187
[TBL] [Abstract][Full Text] [Related]
58. A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus.
Anguiano-Zarate SS; Matchett WE; Nehete PN; Sastry JK; Marzi A; Barry MA
J Infect Dis; 2018 Nov; 218(12):1883-1889. PubMed ID: 29982595
[TBL] [Abstract][Full Text] [Related]
59. Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.
Duehr J; Wohlbold TJ; Oestereich L; Chromikova V; Amanat F; Rajendran M; Gomez-Medina S; Mena I; tenOever BR; García-Sastre A; Basler CF; Munoz-Fontela C; Krammer F
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592526
[TBL] [Abstract][Full Text] [Related]
60. Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.
Blaney JE; Marzi A; Willet M; Papaneri AB; Wirblich C; Feldmann F; Holbrook M; Jahrling P; Feldmann H; Schnell MJ
PLoS Pathog; 2013; 9(5):e1003389. PubMed ID: 23737747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
